Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Bumpus

Showing results (81-90 of 131) with videos related to

Pageof 14
Sort By:
Journal of Medicinal Chemistry|October 1, 1973
Solid-phase synthesis of (3-proline,8-isoleucine)-,(1-sarcosine,3-proline,8-isoleucine)-, and (4-phenylalanine,8-isoleucine)angiotensin II as the antagonists of the parent hormoneM C Khosla, M M Hall, R R Smeby, et al.
The Journal of Pathology|January 1, 1983
Differing patterns of altered glucocorticoid secretion in experimental malignant and benign hypertension. Influences upon the lymphoid system and on arterial connective tissue metabolismR E Chatelain, F M Bumpus, C L Chernicky, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1980
In vitro steroidogenic properties of a new hypertension-producing compound isolated from normal human urineE L Bravo, I Saito, T Zanella, et al.
Circulation Research|April 1, 1990
Angiotensin II-forming pathways in normal and failing human heartsH Urata, B Healy, R W Stewart, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1974
Angiotensin analogs: the influence of sarcosine substituted in position 1M M Hall, M C Khosla, P A Khairallah, et al.
European Journal of Pharmacology|January 1, 1971
Competative antagonism of 8-ala-angiotensin II to angiotensins I and II on isolated rabbit aorta and rat colonR K Turker, M Y Yamamoto, P A Khairallah, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1976
[Therepeutic effect of an angiotensin II antagonist in experimental malignant nephrosclerosis]U Helmchen, M C Khosla, S Sen, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1974
Lack of evidence for a plasma humoral factor of extrarenal origin causing release of reninC Polomski, A Piwonska, N B Oza, et al.
Life Sciences|February 18, 1985
A cardiac specific analog of angiotensin I potentiated by converting enzyme inhibitionR B Cross, C Dallemagne, E Beswick, et al.
Endocrinology|June 1, 1984
Biochemical and immunological properties of dog brain isoreninA Husain, R R Smeby, D Wilk, et al.
Pageof 14

Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Journal of Medicinal Chemistry|October 1, 1973
Solid-phase synthesis of (3-proline,8-isoleucine)-,(1-sarcosine,3-proline,8-isoleucine)-, and (4-phenylalanine,8-isoleucine)angiotensin II as the antagonists of the parent hormoneM C Khosla, M M Hall, R R Smeby, et al.
The Journal of Pathology|January 1, 1983
Differing patterns of altered glucocorticoid secretion in experimental malignant and benign hypertension. Influences upon the lymphoid system and on arterial connective tissue metabolismR E Chatelain, F M Bumpus, C L Chernicky, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1980
In vitro steroidogenic properties of a new hypertension-producing compound isolated from normal human urineE L Bravo, I Saito, T Zanella, et al.
Circulation Research|April 1, 1990
Angiotensin II-forming pathways in normal and failing human heartsH Urata, B Healy, R W Stewart, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1974
Angiotensin analogs: the influence of sarcosine substituted in position 1M M Hall, M C Khosla, P A Khairallah, et al.
European Journal of Pharmacology|January 1, 1971
Competative antagonism of 8-ala-angiotensin II to angiotensins I and II on isolated rabbit aorta and rat colonR K Turker, M Y Yamamoto, P A Khairallah, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1976
[Therepeutic effect of an angiotensin II antagonist in experimental malignant nephrosclerosis]U Helmchen, M C Khosla, S Sen, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1974
Lack of evidence for a plasma humoral factor of extrarenal origin causing release of reninC Polomski, A Piwonska, N B Oza, et al.
Life Sciences|February 18, 1985
A cardiac specific analog of angiotensin I potentiated by converting enzyme inhibitionR B Cross, C Dallemagne, E Beswick, et al.
Endocrinology|June 1, 1984
Biochemical and immunological properties of dog brain isoreninA Husain, R R Smeby, D Wilk, et al.
Pageof 14